Zdrowie i gospodarka · 05/09/2001

FDA Approves Marbofloxacin Tablets for Cats to Treat Bacterial Infections

The US Food and Drug Administration (FDA) has amended its animal drug regulations to approve Pfizer's supplemental new animal drug application (NADA) for marbofloxacin tablets in cats, allowing for the treatment of bacterial infections susceptible to the drug.